The nation of Zimbabwe has rejected a substantial American healthcare agreement valued at 367 million US dollars (272 million pounds) over five years because of Washington's demand for confidential biological samples.
The decision was revealed following a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the agreement was "lopsided".
An official spokesperson has since stated that the United States was demanding access to genetic material for scientific study and commercial gain while refused to share the resulting advantages from future treatments.
"We are forced to start the challenging and unfortunate process of winding down our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had donated over $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has called for further negotiations to reach a agreement suitable to both sides so the country's vital HIV programme can proceed.
Wider Background
This development comes after a similar case in neighbouring Kenya, where a court suspended a similar health funding agreement after concerns were filed about the safety of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
USAID had administered assistance for the American government, but Trump claimed its spending was "inefficient" and his administration was seeking direct bilateral deals to boost transparency and accountability.
Based on reports, Sixteen nations in Africa have so far agreed to these new health pacts, constituting over $18.3bn in committed funds.
Specifics of the Declined Agreement
The funds for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment through US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "unequal".
"Our nation was requested to provide its genetic material and health information over an extended period, with no corresponding assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.
"Effectively, our nation would provide the basic resources for scientific discovery with no certainty that the end products would be accessible to our population should a new health crisis emerge."
Sovereignty and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its push of bilateral deals were undermining structures already established via the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to deal with future pandemics.
"This mechanism is designed to ensure that when a country provides its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," he added.
"We encourage ongoing dialogue with our American counterparts on how future collaboration might be designed in a manner that respects the sovereignty and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but recommended that talks must proceed given that a large portion of the nation's Aids initiatives depended on foreign aid.
"If specific concerns arise, such as those relating to information security or agreement terms, these can often be addressed via technical clarification and mutually agreed protections," it said.
This impasse emphasises the complex debate between receiving crucial international aid and safeguarding a country's data in an increasingly interconnected world.